ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome (EXCELLENCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04304482

Recruitment Status : Completed

First Posted : March 11, 2020

Last Update Posted : August 21, 2023

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

Anavex Australia Pty Ltd.

Anavex Germany GmbH

Information provided by (Responsible Party):

Anavex Life Sciences Corp.

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	June 1, 2023
Actual Study Completion Date :	June 30, 2023

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Heussler HS. Emerging Therapies and challenges for individuals with Angelman syndrome. Curr Opin Psychiatry. 2021 Mar 1;34(2):123-128. doi: 10.1097/YCO.0000000000000674. Erratum In: Curr Opin Psychiatry. 2021 Sep 1;34(5):514.

To Top